System and method for serum based cancer detection
US11145411B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2013 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Nov 6, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01J3/4406
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A system and method for analyzing biological samples, such as dried human blood serum, to determine a disease state such as colorectal cancer (CRC). Using dried samples may hold potential for enhancing localized concentration and/or segmentation of sample components. The method may comprise illuminating at least one location of a biological sample to generate a plurality of interacted photons, collecting the interacted photons and generating at least one Raman data set representative of the biological sample. A system may comprise an illumination source to illuminate at least one location of a biological sample and generate at least one plurality of interacted photons, at least one mirror for directing the interacted photons to a detector. The detector may be configured to generate at least one Raman data set representative of the biological sample. The system and method may utilize a FAST device for multipoint analysis or may be configured to analyze a sample using a line scanning configuration.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.